Yellanki Jagannadham

Title: Yellanki Jagannadham and Pharmaceutical Innovation.

Introduction

Yellanki Jagannadham is an inventor based in Bengaluru, India. His patent work concerns pharmaceutical chemistry and the preparation of compounds intended for potential use in treating multiple sclerosis. He is associated with Cipla Limited.

Latest Patents

The supplied information identifies one patent associated with Jagannadham: “Methods for the Preparation of Sphingosine 1-Phosphate Receptor Modulators and Solid Forms Thereof.” 1 patent.

The invention describes processes for preparing 1-(4-{1-[(E)-4-cyclohexyl-3-trifluoromethyl-benzyloxy imino]ethyl}-2-ethyl-benzyl)-azetidine-3-carboxylic acid, along with intermediates, salts, and solid forms. It also covers pharmaceutical compositions containing the salts and solid forms, and their proposed use in treating multiple sclerosis, particularly secondary progressive multiple sclerosis.

Career Highlights

Jagannadham’s listed patent reflects work on the preparation and formulation of a pharmaceutical compound. The disclosed subject matter includes both manufacturing processes and solid forms, which are relevant to developing pharmaceutical compositions.

Collaborations

The supplied information names Ramanaiah Chennuru and Durga Surya Narayana Yarra as coworkers. Jagannadham is associated with Cipla Limited, a pharmaceutical company.

Conclusion

Yellanki Jagannadham’s identified patent focuses on methods and pharmaceutical forms for a sphingosine 1-phosphate receptor modulator, with proposed applications in multiple sclerosis treatment.